Cargando…

FDG-PET Response Prediction in Pediatric Hodgkin’s Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value

Background: In pediatric Hodgkin’s lymphoma (pHL) early response-to-therapy prediction is metabolically assessed by (18)F-FDG PET carrying an excellent negative predictive value (NPV) but an impaired positive predictive value (PPV). Aim of this study was to improve the PPV while keeping the optimal...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussien, Amr Elsayed M., Furth, Christian, Schönberger, Stefan, Hundsdoerfer, Patrick, Steffen, Ingo G., Amthauer, Holger, Müller, Hans-Wilhelm, Hautzel, Hubertus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381259/
https://www.ncbi.nlm.nih.gov/pubmed/25635760
http://dx.doi.org/10.3390/cancers7010287
_version_ 1782364419839229952
author Hussien, Amr Elsayed M.
Furth, Christian
Schönberger, Stefan
Hundsdoerfer, Patrick
Steffen, Ingo G.
Amthauer, Holger
Müller, Hans-Wilhelm
Hautzel, Hubertus
author_facet Hussien, Amr Elsayed M.
Furth, Christian
Schönberger, Stefan
Hundsdoerfer, Patrick
Steffen, Ingo G.
Amthauer, Holger
Müller, Hans-Wilhelm
Hautzel, Hubertus
author_sort Hussien, Amr Elsayed M.
collection PubMed
description Background: In pediatric Hodgkin’s lymphoma (pHL) early response-to-therapy prediction is metabolically assessed by (18)F-FDG PET carrying an excellent negative predictive value (NPV) but an impaired positive predictive value (PPV). Aim of this study was to improve the PPV while keeping the optimal NPV. A comparison of different PET data analyses was performed applying individualized standardized uptake values (SUV), PET-derived metabolic tumor volume (MTV) and the product of both parameters, termed total lesion glycolysis (TLG); Methods: One-hundred-eight PET datasets (PET1, n = 54; PET2, n = 54) of 54 children were analysed by visual and semi-quantitative means. SUVmax, SUVmean, MTV and TLG were obtained the results of both PETs and the relative change from PET1 to PET2 (Δ in %) were compared for their capability of identifying responders and non-responders using receiver operating characteristics (ROC)-curves. In consideration of individual variations in noise and contrasts levels all parameters were additionally obtained after threshold correction to lean body mass and background; Results: All semi-quantitative SUV estimates obtained at PET2 were significantly superior to the visual PET2 analysis. However, ΔSUVmax revealed the best results (area under the curve, 0.92; p < 0.001; sensitivity 100%; specificity 85.4%; PPV 46.2%; NPV 100%; accuracy, 87.0%) but was not significantly superior to SUVmax-estimation at PET2 and ΔTLGmax. Likewise, the lean body mass and background individualization of the datasets did not impove the results of the ROC analyses; Conclusions: Sophisticated semi-quantitative PET measures in early response assessment of pHL patients do not perform significantly better than the previously proposed ΔSUVmax. All analytical strategies failed to improve the impaired PPV to a clinically acceptable level while preserving the excellent NPV.
format Online
Article
Text
id pubmed-4381259
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-43812592015-05-04 FDG-PET Response Prediction in Pediatric Hodgkin’s Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value Hussien, Amr Elsayed M. Furth, Christian Schönberger, Stefan Hundsdoerfer, Patrick Steffen, Ingo G. Amthauer, Holger Müller, Hans-Wilhelm Hautzel, Hubertus Cancers (Basel) Article Background: In pediatric Hodgkin’s lymphoma (pHL) early response-to-therapy prediction is metabolically assessed by (18)F-FDG PET carrying an excellent negative predictive value (NPV) but an impaired positive predictive value (PPV). Aim of this study was to improve the PPV while keeping the optimal NPV. A comparison of different PET data analyses was performed applying individualized standardized uptake values (SUV), PET-derived metabolic tumor volume (MTV) and the product of both parameters, termed total lesion glycolysis (TLG); Methods: One-hundred-eight PET datasets (PET1, n = 54; PET2, n = 54) of 54 children were analysed by visual and semi-quantitative means. SUVmax, SUVmean, MTV and TLG were obtained the results of both PETs and the relative change from PET1 to PET2 (Δ in %) were compared for their capability of identifying responders and non-responders using receiver operating characteristics (ROC)-curves. In consideration of individual variations in noise and contrasts levels all parameters were additionally obtained after threshold correction to lean body mass and background; Results: All semi-quantitative SUV estimates obtained at PET2 were significantly superior to the visual PET2 analysis. However, ΔSUVmax revealed the best results (area under the curve, 0.92; p < 0.001; sensitivity 100%; specificity 85.4%; PPV 46.2%; NPV 100%; accuracy, 87.0%) but was not significantly superior to SUVmax-estimation at PET2 and ΔTLGmax. Likewise, the lean body mass and background individualization of the datasets did not impove the results of the ROC analyses; Conclusions: Sophisticated semi-quantitative PET measures in early response assessment of pHL patients do not perform significantly better than the previously proposed ΔSUVmax. All analytical strategies failed to improve the impaired PPV to a clinically acceptable level while preserving the excellent NPV. MDPI 2015-01-28 /pmc/articles/PMC4381259/ /pubmed/25635760 http://dx.doi.org/10.3390/cancers7010287 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hussien, Amr Elsayed M.
Furth, Christian
Schönberger, Stefan
Hundsdoerfer, Patrick
Steffen, Ingo G.
Amthauer, Holger
Müller, Hans-Wilhelm
Hautzel, Hubertus
FDG-PET Response Prediction in Pediatric Hodgkin’s Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value
title FDG-PET Response Prediction in Pediatric Hodgkin’s Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value
title_full FDG-PET Response Prediction in Pediatric Hodgkin’s Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value
title_fullStr FDG-PET Response Prediction in Pediatric Hodgkin’s Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value
title_full_unstemmed FDG-PET Response Prediction in Pediatric Hodgkin’s Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value
title_short FDG-PET Response Prediction in Pediatric Hodgkin’s Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value
title_sort fdg-pet response prediction in pediatric hodgkin’s lymphoma: impact of metabolically defined tumor volumes and individualized suv measurements on the positive predictive value
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381259/
https://www.ncbi.nlm.nih.gov/pubmed/25635760
http://dx.doi.org/10.3390/cancers7010287
work_keys_str_mv AT hussienamrelsayedm fdgpetresponsepredictioninpediatrichodgkinslymphomaimpactofmetabolicallydefinedtumorvolumesandindividualizedsuvmeasurementsonthepositivepredictivevalue
AT furthchristian fdgpetresponsepredictioninpediatrichodgkinslymphomaimpactofmetabolicallydefinedtumorvolumesandindividualizedsuvmeasurementsonthepositivepredictivevalue
AT schonbergerstefan fdgpetresponsepredictioninpediatrichodgkinslymphomaimpactofmetabolicallydefinedtumorvolumesandindividualizedsuvmeasurementsonthepositivepredictivevalue
AT hundsdoerferpatrick fdgpetresponsepredictioninpediatrichodgkinslymphomaimpactofmetabolicallydefinedtumorvolumesandindividualizedsuvmeasurementsonthepositivepredictivevalue
AT steffeningog fdgpetresponsepredictioninpediatrichodgkinslymphomaimpactofmetabolicallydefinedtumorvolumesandindividualizedsuvmeasurementsonthepositivepredictivevalue
AT amthauerholger fdgpetresponsepredictioninpediatrichodgkinslymphomaimpactofmetabolicallydefinedtumorvolumesandindividualizedsuvmeasurementsonthepositivepredictivevalue
AT mullerhanswilhelm fdgpetresponsepredictioninpediatrichodgkinslymphomaimpactofmetabolicallydefinedtumorvolumesandindividualizedsuvmeasurementsonthepositivepredictivevalue
AT hautzelhubertus fdgpetresponsepredictioninpediatrichodgkinslymphomaimpactofmetabolicallydefinedtumorvolumesandindividualizedsuvmeasurementsonthepositivepredictivevalue